News Salvia's migraine implant could be breakthrough, says FDA An implantable neurostimulation migraine device from Salvia BioElectronics has gained Breakthrough Device Designation from the FDA.
News Sanofi to lay off 229 Blueprint employees, close offices A year after its $9.1bn acquisition of Blueprint Medicines, Sanofi is moving out of Blueprint's Cambridge, MA offices and letting 229 employees go.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.